Malaria Vaccine
Plasmodium vivax MSP1 Pv200L is potential malaria vaccine subunit
Published in Vaccine Weekly, January 25th, 2006
According to a study from Colombia, "The merozoite surface protein 1 (MSP-1) is expressed in all Plasmodium species and is considered a major malaria vaccine candidate. We found that MSP-1 from Plasmodium vivax (PvMSP-1) contains a region of significant sequence homology with the 190L subunit vaccine derived from the P. falciparum MSP-1."
"The fragment, termed Pv200L, was expressed as a recombinant protein in Escherichia coli (rPv200L) and used to asses its immunologic relevance as a vaccine target. A cross-sectional, sero-epidemiologic study...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-01-25)
More Articles from Vaccine Weekly
- Anthrax Vaccine
Mice immunized with chloroplast-derived anthrax antigen survive lethal challenge - Malaria Vaccine
Epitopes delivered by polymeric linear peptides protect against malaria - Meningitis Vaccine
N. meningitidis conjugate vaccine induces protective antibodies - Trichomoniasis Vaccine
Proteinase plus adjuvant prevent Trichomonas genital infections - Tularemia Vaccine
Attenuated Francisella tularensis mutant is an effective live vaccine - Adenovirus Vaccine
Review focused on inactivating antiviral responses during adenovirus infection - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
